You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD39

Showing 1 - 25 of 3,304
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer Circulating Tumor Cells

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Sample
  • Nice, France
    CHU de Nice
Dec 5, 2022

HNSCC, Melanoma, Gynecologic Cancer Trial in Portland (DP CD8 TIL, DP CD8 TIL KD, Low dose IL-2)

Recruiting
  • HNSCC
  • +5 more
  • DP CD8 TIL
  • +2 more
  • Portland, Oregon
    Providence Portland Medical Center
Jun 5, 2023

Advanced Solid Tumor Trial (ES014)

Withdrawn
  • Advanced Solid Tumor
  • (no location specified)
Jan 30, 2023

Advanced Solid Tumors Trial in Guangdong (JS019)

Recruiting
  • Advanced Solid Tumors
  • JS019
  • Guangdong, Guangzhou, China
    Guangdong General Hospital
Aug 17, 2022

Advanced Solid Tumor Trial in United States (Part 1 ES002023, Part 2 ES002023)

Active, not recruiting
  • Advanced Solid Tumor
  • Part 1 ES002023
  • Part 2 ES002023
  • Scottsdale, Arizona
  • +6 more
Oct 18, 2022

HIV Trial in United States (BG505 MD39.3 mRNA, BG505 MD39.3 gp151 mRNA, BG505 MD39.3 gp151 CD4KO mRNA)

Suspended
  • HIV Infections
  • BG505 MD39.3 mRNA
  • +2 more
  • Birmingham, Alabama
  • +9 more
Feb 1, 2023

Advanced Solid Tumors or Lymphomas Trial in Beijing (JS019)

Recruiting
  • Advanced Solid Tumors or Lymphomas
  • JS019
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 9, 2022

Solid Tumor, Adult Trial in Korea, Republic of, United States (TTX-030, budigalimab and mFOLFOX6, TTX-030, budigalimab and

Active, not recruiting
  • Solid Tumor, Adult
  • TTX-030, budigalimab and mFOLFOX6
  • +7 more
  • Scottsdale, Arizona
  • +31 more
Oct 18, 2022

Vulva Cancer, Vulva Tumor, Squamous Cell Cancer Trial (Pembrolizumab)

Not yet recruiting
  • Vulva Cancer
  • +2 more
  • (no location specified)
Mar 7, 2023

CD73+ Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis

Completed
  • Rheumatoid Arthritis
  • Psoriatic Arthritis
  • Multi-parametric Flow Cytometry analysis on patients and healthy donors samples
  • Pierre-Bénite, France
    Service de Rhumatologie, Centre Hospitalier Lyon-Sud (HCL)
May 15, 2019

Purinergic Signaling and the Postmenopausal Heart

Recruiting
  • Diastolic Heart Failure
  • Heart Failure With Preserved Ejection Fraction
  • Gender
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Aug 28, 2023

Tumor and Peripheral Blood to Evaluate Efficacy of Cancer

Recruiting
  • Lung Cancer
  • Esophageal Cancer
  • In vitro stimulation of Pbmc with tumor antigen nanoparticles
  • Suzhou, Jiangsu, China
    The first affiliated hospital of soochow university
Mar 16, 2023

Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial (ES014)

Not yet recruiting
  • Solid Tumor
  • +2 more
  • (no location specified)
Jan 28, 2023

Advanced Solid Tumors Trial in Houston (PUR001)

Recruiting
  • Advanced Solid Tumors
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Jan 18, 2023

Cancer Trial in Genova (Short-term modified fasting)

Recruiting
  • Cancer
  • Short-term modified fasting
  • Genova, Italy
    San Martino Hospital
Feb 17, 2023

Advanced Solid Tumor Trial in Canada, United States (SRF617, Gemcitabine, Albumin-Bound Paclitaxel)

Active, not recruiting
  • Advanced Solid Tumor
  • Duarte, California
  • +9 more
Nov 28, 2022

Pancreatic Cancer Trial (TTX-030, nab-paclitaxel and gemcitabine, TTX-030, budigalimab, nab-paclitaxel and gemcitabine,

Not yet recruiting
  • Pancreatic Cancer
  • TTX-030, nab-paclitaxel and gemcitabine
  • +2 more
  • (no location specified)
Nov 3, 2023

Substance Use Disorders Trial in Newark (Critical Dialogue, Capacity Building Project, Quality of Life Wheel)

Completed
Has Results
  • Substance Use Disorders
  • Critical Dialogue
  • +4 more
  • Newark, New Jersey
    Integrity House
Nov 29, 2022

Deficient T Regulatory Cell Function in Relapsing Remitting

Recruiting
  • Relapse Remitting Multiple Sclerosis
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Jun 13, 2022

    "Don't Eat me" Signal in Hematological Malignancies: CD24 as New

    Recruiting
    • Mantle-cell Lymphoma
    • B Cell Chronic Lymphocytic Leukemia
      • Monza, MB, Italy
        Andrea Aroldi
      May 24, 2023

      Oligorecurrent and Oligoprogressive Prostate Cancer Patients Trial in Rozzano (procedure, drug, biological)

      Recruiting
      • Oligorecurrent and Oligoprogressive Prostate Cancer Patients
      • Radiotherapy
      • +2 more
      • Rozzano, Milano, Italy
        Humanitas Research Hospital
      May 3, 2022

      Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and

      Recruiting
      • Malignant Glioma of Brain
      • +8 more
      • Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
      • Detroit, Michigan
        Henry Ford Health System
      Jan 9, 2023

      Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in United States (SRF617, etrumadenant, zimberelimab)

      Recruiting
      • Metastatic Castration-resistant Prostate Cancer
      • Prostate Cancer
      • Miami, Florida
      • +6 more
      Jun 13, 2022

      Parkinson's Disease Trial in Worldwide (IPX066, IR CD-LD)

      Completed
      Has Results
      • Parkinson's Disease
      • Birmingham, Alabama
      • +72 more
      Aug 7, 2020

      Primary Immune Thrombocytopenia Trial in Singapore (Ianalumab, Eltrombopag, Placebo)

      Recruiting
      • Primary Immune Thrombocytopenia
      • Ianalumab
      • +2 more
      • Singapore, Singapore
        Novartis Investigative Site
      Jan 23, 2023